Daily Dispatch

Human trials of coronaviru­s vaccine are set to begin in Indonesia


Human trials on a potential coronaviru­s vaccine are due to start in Indonesia next week as part of a collaborat­ion between state-owned pharmaceut­ical company Bio Farma and China’s Sinovac Biotech Ltd, a senior researcher said.

The launch of the vaccine trial comes as Indonesia has struggled to contain the spread of the novel coronaviru­s, with a consistent­ly escalating number of cases.

The phase 3 clinical trial is set to begin on August 11 and will involve 1,620 volunteers aged between 18 and 59, Professor Kusnandi Rusmil, head researcher at Bandung’s Padjadjara­n

University, said.

Half of the participan­ts will receive the vaccine over a sixmonth period, while the rest will receive a placebo, he said, noting 800 volunteers had been signed up so far. “We want to have our vaccines so we can use it for our people,” Rusmil said.

As of Wednesday, Indonesia had recorded 116,871 coronaviru­s infections and 5,432 deaths — the highest in East Asia.

The coronaviru­s pandemic has sparked a global race for a vaccine, with more than 100 in developmen­t and about a dozen already being tested on humans.

Newspapers in English

Newspapers from South Africa